Browse recent medication, recall, and health-related stories.
Page 49 of 51
Key corporate developments, order wins, regulatory updates and bulk deals are likely to keep several stocks in focus on July 13
Staying active is good for your wallet as well as your health. One of the best ways to maintain an active lifestyle is to choose a city that encourages and facilitates recreation. The best cities have a wide range of...
Business Wire India Takeda (TSE:4502/NYSE:TAK) and the Indonesian Government (the Ministry of Health, the Ministry of Investment and Downstream Industry/BKPM and the Coordinating Ministry for Economic Affairs) today announced a...
New evidence on semaglutide and tirzepatide shows impressive weight loss, but also raises concerns about muscle loss, weight regain and the cost of lifelong treatment
The US Food and Drug Administration (FDA) issued a proposed rule that, if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a single
A Human-Safe Drug Reduces Multiple Signs of Alzheimer's in Mice ScienceAlert Spinal Cord Injury Drug Shows Promise for Alzheimer’s Disease Technology Networks
(RTTNews) - Merck & Co Inc. (MRK) announced that the U.S. Food and Drug Administration approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph), the company's anti-PD-1 therapies, each in combination with Padcev (enfortumab vedotin-ejfv). These regimens are now authorized as neoadjuvant treatment before...
Get latest articles and stories on India at LatestLY. The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013.
The National Pharmaceutical Pricing Authority has capped prices for 39 essential medicines. These drugs are commonly used for diabetes and high blood pressure management. Calcium and Vitamin D3 tablets now have a fixed retail price. Anti-Rabies Immunoglobulin injection prices were also revised by the authority. This move aims to make healthcare more affordable for many patients.
Business Wire India Takeda (TSE:4502/NYSE:TAK) and the Indonesian Government (the Ministry of Health, the Ministry of Investment and Downstream Industry/BKPM and the Coordinating Ministry for Economic Affairs) today announced a...
(RTTNews) - Merck & Co Inc. (MRK) announced that the U.S. Food and Drug Administration approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph), the company's anti-PD-1 therapies, each in combination with Padcev (enfortumab vedotin-ejfv). These regimens are now authorized as neoadjuvant treatment before...
The National Pharmaceutical Pricing Authority has capped prices for 39 essential medicines. These drugs are commonly used for diabetes and high blood pressure management. Calcium and Vitamin D3 tablets now have a fixed retail price. Anti-Rabies Immunoglobulin injection prices were also revised by the authority. This move aims to make healthcare more affordable for many patients.